Reviva Pharmaceuticals Holdings Inc (NASDAQ:RVPH) currently has a daily average trading volume of 452.09K but it saw 1695157 shares traded in last market. With a market cap of 47.82M USD, the company’s current market price of $1.43 came rising about 14.40 while comparing to the previous closing price of $1.25. In past 52 weeks, the stock remained buoying in the range of price level as high as $5.67 and as low as $0.60. In the recent trading on the day, stock has struck highest price mark of $1.21 while lowest mark touched by it was $1.48.
Taking a look at 20-day trading activity of Reviva Pharmaceuticals Holdings Inc (RVPH) gives us an average price of $1.1801, while its current price level is -74.78% below from 52-week high level whereas it is 138.33% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $1.2008 while that of 200 days or SMA-200 reads an average of $1.8099. A closer look into the stock’s movement over the week reveals that its volatility is standing at 12.23% during that period while stretching the period over a month that increases to 13.62%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 63.50 which implies that the stock is in neutral territory.
The company’s shares got several price updates from the analyst firms in past one month and most recent of them is from the ROTH MKM which initiated the stock as “Buy” in its note to investors issued on September 20, 2023, recommending a price target of $12 for it. H.C. Wainwright also issued its recommendations for the stock as it initiated the price target for the stock is $10.
Over the week, RVPH’s stock price is moving 25.44% up while it is 56.16% when we observe its performance for the past one month. Year-to-date it is -72.23% down and over the past year, the stock is showing a downside performance of -62.66%.
The latest quarterly earnings report issued by the company reported quarterly earnings per share (EPS) of -0.35 beat the consensus estimate of -0.37 for the same. The company is expected to be releasing its next quarterly report in January, for which analysts forecasted an EPS of -0.23 while estimate for next year EPS is -1.0.
Currently, Reviva Pharmaceuticals Holdings Inc’s total number of outstanding shares is 33.44M. Company’s return on equity (ROE) at -1806.28%. Stock’s beta reads -0.02. Its return on asset (ROA) is -512.93% on average.
